Anna Calderone
Dermatology · Marlton, NJNPI 1487394193
Payments from drug & device makers
Across 323 payments — averaging $27.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$4K
- AbbVie$754
- Regeneron Healthcare Solutions, Inc.$606
- Sun Pharmaceutical Industries Inc.$456
- Sanofi$417
- Incyte Corporation$355
- plus $2K from 20 others
What the payments were for
- Consulting fees$1,88821%
- Travel & lodging$93310%
- Food & beverage$5,76064%
- Education$4515%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 67 | $4,147 |
| AbbVie | 63 | $754 |
| Regeneron Healthcare Solutions, Inc. | 18 | $606 |
| Sun Pharmaceutical Industries Inc. | 19 | $456 |
| Sanofi | 18 | $417 |
| Incyte Corporation | 14 | $355 |
| Pfizer | 22 | $343 |
| Amgen | 14 | $334 |
| Johnson & Johnson | 7 | $209 |
| Lilly USA, LLC | 10 | $179 |
| LEO Pharma Inc. | 11 | $162 |
| Novartis | 9 | $158 |
| Galderma Laboratories, L.p. | 8 | $157 |
| UCB, Inc. | 2 | $142 |
| Arcutis Biotherapeutics, Inc. | 12 | $128 |
| Sanofi-aventis U.S. LLC | 1 | $95 |
| Biofrontera Inc. | 5 | $76 |
| Mayne Pharma Commercial LLC | 3 | $60 |
| Boehringer Ingelheim | 3 | $49 |
| Dermavant Sciences, Inc. | 3 | $47 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $45 |
| Organon | 6 | $37 |
| Journey Medical Corporation | 2 | $29 |
| Verrica Pharmaceuticals Inc. | 1 | $17 |
| Botanix SB Inc | 1 | $16 |
| Mission Pharmacal Company | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,033 in reported general payments places this provider in the 75th percentile of 394 dermatology providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SotyktuDeucravacitinib | 23 | $156,618 |
| Doxycycline Ir-DrDoxycycline Monohydrate | 22 | $25,498 |
| Ketoconazole | 108 | $1,553 |
| Doxycycline Hyclate | 18 | $1,301 |
| Clobetasol Propionate | 22 | $969 |
| Calcipotriene | 12 | $878 |
| Ciclopirox | 13 | $809 |
| Mometasone Furoate | 29 | $681 |
| Halobetasol Propionate | 24 | $670 |
| Fluorouracil | 13 | $639 |
| Hydrocortisone | 29 | $412 |
| Triamcinolone Acetonide | 47 | $342 |
| Imiquimod | 14 | $245 |
| Mupirocin | 35 | $231 |
| ValacyclovirValacyclovir Hcl | 12 | $226 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| E.r. Squibb & Sons, L.L.C.Sotyktu | $4,147 | $156,61823 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 394 dermatology providers in New Jersey.
Other dermatology in Marlton
- Patrick McMahonMarlton$133K
- Camille IntrocasoMarlton$23K
- Jerry BagelEast Windsor$15.4M
- Jonathan DosikGlen Rock$8.4M
- Omar NoorSomerset$4.6M
- Linda Cappiello-LindsleyHoboken$2.3M
- Winston MoyDenville$1.8M
- Brian KeeganEast Windsor$1.7M
- Jeanine DownieMontclair$1.2M
- Adolfo Fernandez ObregonHoboken$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.